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Introduction
The centrosome plays a fundamental role in most microtubule- 
related functions, including cell motility, intracellular transport, 
and chromosome segregation (Gönczy, 2012; Conduit et al., 
2015). Centrosomes have at their core a pair of centrioles that 
duplicate once per cell cycle to allow a single interphase cen-
trosome to reproduce once before mitosis (Tsou and Stearns, 
2006). The two centrosomes then separate and form the poles of 
the bipolar spindle apparatus upon which chromosomes are seg-
regated. Errors in centriole duplication can lead to an abnormal 
centrosome number, which disrupts the fidelity of cell division 
and leads to the production of aneuploid progeny (Ganem et al., 
2009; Silkworth et al., 2009).
Polo-like kinase 4 (Plk4) is the conserved, master regu-
lator of centriole copy number (Bettencourt-Dias et al., 2005; 
Habedanck et al., 2005). In nontransformed human cells, in-
hibition of Plk4 kinase activity or induced degradation of Plk4 
leads to centrosome loss and a p53-dependent cell cycle arrest 
within a few cell divisions (Lambrus et al., 2015; Wong et al., 
2015). This arrest is not caused by mitotic errors, Hippo path-
way activation, p38-mediated stress signaling, or DNA damage 
(Lambrus et al., 2015; Wong et al., 2015). Genetic inactivation 
of the centriole protein SAS4 in the mouse embryo or in the 
developing mouse brain also results in centrosome loss, de-
layed spindle assembly, and p53-dependent apoptosis (Bazzi 
and Anderson, 2014; Insolera et al., 2014). Together, these 
studies implicate the existence of a new signaling pathway that 
activates p53 in response to a signal linked to centrosome loss. 
For simplicity, we hereafter refer to this pathway as the centro-
some surveillance pathway.
Although centrosomes are required for the sustained pro-
liferation of nontransformed mammalian cells, a wide array of 
tumor cells are able to continue to proliferate after centrosome 
loss (Wong et al., 2015). Cell divisions that lack centrosomes 
are error prone (Khodjakov and Rieder, 2001; Debec et al., 
2010; Sir et al., 2013; Lambrus et al., 2015), suggesting that 
the centrosome surveillance pathway could protect against ge-
nome instability by preventing the growth of cells with too few 
centrosomes. Nevertheless, it remains unclear how p53 is acti-
vated in response to centrosome loss in mammalian cells. Here, 
we explore the genetic basis for signaling through the centro-
some surveillance pathway.
Results and discussion
A chemical genetic system to activate the 
centrosome surveillance pathway
We set out to develop a chemical genetic system to specifi-
cally inhibit Plk4 kinase activity and induce centrosome loss in 
human cells. Mutation of a single amino acid in the ATP-binding 
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pocket of Plk4 creates an analogue-sensitive (AS) kinase that 
can be inhibited with nonhydrolyzable, bulky ATP analogues 
(Fig. 1 A; Holland et al., 2010; Moyer et al., 2015). We used 
CRI SPR/Cas9 to knock in the Plk4 AS mutation (L89G) into 
the endogenous Plk4 locus in nontransformed hTERT-RPE1 
cells (Fig. 1 B). A clone was identified carrying a frameshift, 
knockout mutation in one Plk4 allele and an AS knockin muta-
tion in the second allele. The Plk4AS/− cells (hereafter referred 
to as Plk4AS) proliferated at the same rate as the parental cells 
and contained normal numbers of centrioles (Fig. 1, C and D). 
As expected, inhibition of Plk4 kinase activity with 3MB-PP1 
led to an increase in Plk4 levels at the centrosome and a failure 
of centriole duplication (Fig. S1 A and Fig. 1 C).
Although RPE1 cells proliferated normally in the pres-
ence of 3MB-PP1, addition of 3MB-PP1 to Plk4AS cells resulted 
in a penetrant G1 cell cycle arrest after 3 d (Figs. 1 D and S1 B). 
As a consequence, centriole loss ceased after 4 d of treatment 
with 3MB-PP1 (Fig. 1 C). To evaluate the long-term growth po-
tential of cells that lack Plk4 kinase activity, we performed clo-
nogenic survival assays. 3MB-PP1 addition prevented colony 
formation in Plk4AS RPE1 cells but did not affect the survival of 
parental RPE1 cells (Fig. S1 C). The arrest was not caused by 
oxidative stress, as growth in low oxygen (3% O2) did not allow 
continued growth after centrosome loss (Fig. S1 D). A similar 
growth arrest was previously reported in RPE1 cells that lose 
centrosomes as a result of destruction of endogenous Plk4 or 
treatment with the ATP-competitive Plk4 inhibitor centrinone 
(Lambrus et al., 2015; Wong et al., 2015). We conclude that 
inhibition of Plk4AS kinase activity provides a system to activate 
the centrosome surveillance pathway in RPE1 cells.
Genome-scale CRI SPR/Cas9 knockout 
screen to identify components of the 
centrosome surveillance pathway
To identify novel components of the centrosome surveillance 
pathway, we used Plk4AS RPE1 cells to perform a genome-wide, 
loss-of-function CRI SPR/Cas9 screen. We generated Plk4AS 
cells stably expressing the SpCas9 endonuclease and trans-
duced them with a genome-wide single guide RNA (sgRNA) li-
brary (Shalem et al., 2014). Knockout libraries of RPE1 Plk4AS 
cells were cultured in the presence of DMSO or 3MB-PP1 for 
42 d. Cells that lacked genes required for the centrosome sur-
veillance pathway were expected to proliferate in the absence 
of Plk4 kinase activity and enrich in the 3MB-PP1–treated 
population compared with DMSO treated controls (Fig. 2 A). 
Deep sequencing revealed that the sgRNA distribution in 
3MB-PP1–treated cells was significantly different compared 
with DMSO-treated cells (Fig. 2 B). The two highest-ranking 
genes in the screen were p53 and 53BP1 (false discovery rate 
<0.05; Fig.  2, C and D; and Fig. S1 E). Importantly, 53BP1 
interacts directly with p53 but has not been previously impli-
cated in the centrosome surveillance pathway (Iwabuchi et al., 
1994; Joo et al., 2002).
To confirm 53BP1 as a novel hit, we repeated the CRI SPR/ 
Cas9 screen in SpCas9-expressing hTERT-RPE1 cells using the 
Plk4 inhibitor centrinone (Wong et al., 2015). p53 and 53BP1 
emerged again as the top hits from this screen (false discovery 
rate <0.05; Fig. 2, E–G). To validate the role of 53BP1 in the 
centrosome surveillance pathway, we generated knockouts of 
p53 and 53BP1 in Plk4AS cells. Inactivation of p53 or 53BP1 
dramatically increased the clonogenic survival of Plk4AS cells 
treated with 3MB-PP1 (Figs. 2 H and S1 F). Thus, our unbiased, 
genome-scale screening identified 53BP1 as a novel component 
of the centrosome surveillance pathway.
53BP1 is required to stabilize p53 after 
centrosome loss
Knockout of p53 did not alter the levels of 53BP1 and vice 
versa, showing these proteins are not required for one another’s 
stability (Fig. 3, A and B). To test whether cells lacking 53BP1 
lose centrosomes in the absence of Plk4 activity, we examined 
centriole number in p53 and 53BP1 knockout Plk4AS cells over 
Figure 1. Inhibition of AS Plk4 leads to centrosome loss 
and growth arrest. (A) Principle of AS Plk4 and its inhibition 
by 3MB-PP1. (B) Schematic of sgRNA and repair template 
oligo used to knock in the AS mutation at endogenous Plk4 
genomic loci. sgRNA sequence is highlighted in blue, and 
edited nucleotides are displayed in red. (C) Centriole number 
distribution in interphase Plk4AS cells at time points after addi-
tion of 3MB-PP1. Data are means ± SEM of three independent 
experiments (n = 3) with >80 cells per experiment. (D) Fold 
increase in cell number after 3MB-PP1 addition. Data are 
means ± SEM (n = 2, performed in triplicate). WT, wild type.
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the course of 1 week after Plk4 inhibition. Treatment of p53−/− 
or 53BP1−/− Plk4AS cells with 3MB-PP1 led to a gradual reduc-
tion in centriole number as cells failed centriole duplication but 
continued to divide. 6 d after 3MB-PP1 treatment, >90% of p53 
and 53BP1 knockout cells lacked centrioles (Fig. 3, C and D).
Centrosome loss increased total cellular and nuclear p53 
levels (Fig. 3 E and Fig. S2 A). Importantly, knockout of 53BP1 
prevented p53 stabilization in response to centrosome loss, sug-
gesting that 53BP1 functions upstream of p53 in the centrosome 
surveillance pathway (Figs. 3 F and S2 A). Knockout of 53BP1 
did not, however, prevent stabilization of p53 in response to 
doxorubicin-induced DNA damage (Fig. S2 A), showing that 
53BP1 is not required for all p53-dependent responses.
USP28 functions together with 53BP1 to 
stabilize p53 after centrosome loss
We considered the possibility that during the selection period 
for the CRI PSR/Cas9 screen, sgRNAs that provide a modest 
growth advantage in cells lacking centrosomes may be outcom-
peted by the faster growth of cells containing sgRNAs targeting 
p53 or 53BP1. To investigate whether weaker hits may have 
been overlooked, we created knockouts for the top 40 ranked 
Figure 2. A genome-wide CRI SPR/Cas9 screen identifies 53BP1 and p53 as components of the centrosome surveillance pathway. (A) Schematic of the 
pooled, positive selection CRI SPR/Cas9 screen used to identify components of the centrosome surveillance pathway. (B) Graph showing the distribution 
of individual sgRNAs. Data are means ± SD. (C) Rank-ordered dot plot showing relative enrichment of individual sgRNAs after 3MB-PP1 treatment. 
(D) Identification of top candidate genes after 3MB-PP1 treatment using the MaGeCK ranking p-value analysis. (E) Graph showing the distribution 
of individual sgRNAs. Data are means ± SD. (F) Rank-ordered dot plot showing relative enrichment of individual sgRNAs after centrinone treatment. 
(G) Identification of top candidate genes after centrinone treatment using the MaGeCK ranking p-value analysis. (H) Graph showing the relative clonogenic 
growth of 3MB-PP1–treated Plk4AS cells expressing individual sgRNAs. Data are means ± SEM (n = 2, performed in duplicate). Representative images of 
crystal violet–stained colonies. ***, P ≤ 0.001.
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genes and analyzed the ability of each sgRNA to promote the 
growth of Plk4AS cells in the presence of 3MB-PP1 (Fig. S1 E). 
Other than p53 and 53BP1, USP28 (ranked #29) was the only 
other sgRNA target that provided a significant growth advantage 
in Plk4AS cells grown in 3MB-PP1 (Fig. 3, G and H; and Fig. 
S1, E and F). Importantly, USP28 is a deubiquitinating enzyme 
that has been shown to interact with 53BP1 (Zhang et al., 2006).
Knockout of USP28 did not alter basal levels of p53 
or prevent p53 stabilization in response to doxorubicin- 
induced DNA damage (Fig. 3 I and Fig. S2, A and B). However, 
USP28−/− cells failed to stabilize p53 in response to centrosome 
loss (Figs. 3 J and S2 A). Cells lacking USP28 grew continu-
ally in the absence of Plk4 activity, and consequently, >90% of 
USP28 knockout cells lacked centrioles after 6 d of 3MB-PP1 
Figure 3. p21 and USP28 are required for the centrosome surveillance pathway. (A and B) Immunoblot showing the levels of p53 or 53BP1 in Plk4AS; 
p53−/− and Plk4AS; 53BP1−/− cells. (C and D) Centriole number distribution in interphase Plk4AS; p53−/− and Plk4AS; 53BP1−/− cells at times after addition 
of 3MB-PP1. Data are means ± SEM (n = 3, >80 cells per experiment). (E and F) Relative abundance of nuclear p53 in Plk4AS and Plk4AS; 53BP1−/− cells at 
times after addition of DMSO or 3MB-PP1. Data are means ± SEM (n = 3, >180 cells per experiment). (G) Relative clonogenic survival of 3MB-PP1–treated 
Plk4AS cells expressing individual sgRNAs. Data are means ± SEM (n = 2, performed in duplicate). (H) Representative images of crystal violet stained col-
onies. (I) Immunoblot showing the level of p53 or 53BP1 protein in Plk4AS; USP28−/− cells. (J) Relative abundance of nuclear p53 in Plk4AS; USP28−/− cells 
at times after addition of DMSO or 3MB-PP1. Data are means ± SEM (n = 3, >180 cells per experiment). (K) Centriole number distribution in interphase 
Plk4AS; USP28−/− cells at 6 d after addition of 3MB-PP1. Data are means ± SEM (n = 3, >80 cells per experiment). (L) Fold increase in cell number after 
3MB-PP1 addition. Data are means ± SEM (n = 2, performed in triplicate). (M) Immunoblot showing the level of p21 or p53 in Plk4AS; p21−/− cells. 
(N) Relative abundance of nuclear p53 in Plk4AS; p21−/− cells at times after addition of DMSO or 3MB-PP1. Data are means ± SEM (n = 3, >180 cells 
per experiment). (O) Centriole number distribution in interphase Plk4AS; p21−/− cells at 6 d after addition of 3MB-PP1. Data are means ± SEM (n = 3, >80 
cells per experiment). ns (nonsignificant), P > 0.05; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001.
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treatment (Fig. 3, K and L; and Fig. S2 C). These data demon-
strate that USP28 acts together with 53BP1 to stabilize p53 in 
response to centrosome loss.
To examine whether USP28 or 53BP1 knockout alters 
basal p53 stability, we examined p53 levels after cyclohexim-
ide addition in USP28−/− and 53BP1−/− cells. Loss of USP28 
and 53BP1 did not alter basal p53 stability in Plk4AS cells (Fig. 
S2 D). Furthermore, inhibiting p53 binding to MDM2 with 
Nutlin-3 elevated p53 levels to a similar extent in wild-type, 
USP28−/−, and 53BP1−/− Plk4AS cells (Fig. S2 E). We conclude 
that USP28 and 53BP1 do not alter p53 regulation by MDM2 or 
modulate basal p53 stability.
Inhibition of Plk4 kinase activity could have consequences 
in addition to prompting a failure of centriole duplication. We 
therefore tested whether loss of SAS6, a conserved structural 
component required for centriole assembly, also prevents cell 
growth and whether this can be overcome by inactivating com-
ponents of the centrosome surveillance pathway (Dammermann 
et al., 2004; Leidel et al., 2005). Consistent with its essential 
role in cell growth, we were unable to generate SAS6 knockout 
clones in hTERT-RPE1 cells (Fig. S2 F). We did, however, iden-
tify multiple clones of USP28−/−, 53BP1−/−, and p53−/− cells 
that lacked SAS6 and centrosomes. These data suggest that 
centrosome loss, and not loss of Plk4 kinase activity per se, is 
responsible for activating the centrosome surveillance pathway.
p21 acts downstream of p53 in the 
centrosome surveillance pathway
The cyclin-dependent kinase inhibitor p21 (CDKN1A) is a 
transcriptional target of p53 that is responsible for promoting a 
p53-dependent G1 arrest in response to a variety of stress stim-
uli. Because p21 also emerged as a weak hit in the CRI SPR/
Cas9 screen (ranked #146; Fig. S1 E), we reasoned that p21 
could contribute to the p53-dependent cell cycle arrest that oc-
curs after centrosome loss. Indeed, p21 levels increased after 
Plk4 inhibition (Fig. S2 A). Knockout of p21 did not alter p53 
abundance or prevent p53 stabilization after centrosome loss, 
consistent with p21 acting downstream of p53 (Fig. 3, M and 
N; and Fig. S2 A). p21 knockout increased the clonogenic sur-
vival of Plk4AS cells in the presence of 3MB-PP1 (Fig. 3, G and 
H; and Fig. S1 F). In addition, p21−/− cells grew continually 
in the presence of 3MB-PP1, and by 6 d after 3MB-PP1 treat-
ment, >90% of Plk4AS; p21−/− cells lacked centrioles (Fig.  3, 
L and O; and Fig. S2 C).
The centrosome surveillance pathway is 
not activated by DNA damage
As USP28, 53BP1, and p53 have all been shown to play a role 
in the DNA damage signaling pathway, we asked whether cells 
that fail centrosome duplication acquire DNA damage. We first 
used immunoblotting to examine changes in the abundance of 
γ-H2AX. Although a brief treatment with doxorubicin increased 
γ-H2AX levels, no increase was observed in Plk4AS cells treated 
with 3MB-PP1 (Fig. 4 A). In addition, doxorubicin-induced DNA 
damage led to robust phosphorylation of the ATM target sites p53 
Ser15 and KAP1 Ser824, but phosphorylation of these sites was 
undetectable in Plk4AS cells grown in the presence of 3MB-PP1 
(Banin et al., 1998; Canman et al., 1998; White et al., 2006; Ziv 
et al., 2006; Fig. 4 A). We next examined 53BP1 foci formation 
using immunofluorescence microscopy. Although doxorubicin 
treatment led to a more than fourfold increase in the number of 
cells with more than five 53BP1 foci, no significant increase in 
foci formation was observed in Plk4AS cells after centrosome du-
plication failure (Fig. 4 B). Collectively, our data offer no evi-
dence for elevated DNA damage in cells that lose centrosomes.
Next, we tested whether proteins that function in the 
DNA damage pathway are required to arrest the cell cycle after 
centrosome loss. Chronic treatment with the ATM inhibitor 
KU-55933 did not prevent a cell cycle arrest after centrosome 
loss (Fig. S3, A and B). Additionally, ATM, RNF8, Chk1, and 
Chk2 are components of the DNA damage response, but knock-
out of these genes did not abolish the centrosome surveillance 
pathway (Fig. S1 E). Importantly, whereas Chk2−/− Plk4AS 
cells did not proliferate in 3MB-PP1, loss of Chk2 attenuated 
DNA damage signaling and rescued cell growth in doxorubicin 
(Fig. 4, C–E). This suggests that the DNA damage response and 
centrosome surveillance are genetically separable pathways.
The E3 ubiquitin ligase RNF168 is required for the re-
cruitment of 53BP1 to sites of DNA double-strand breaks (Doil 
et al., 2009; Mallette et al., 2012; Mallette and Richard, 2012). 
We created RNF168 knockout Plk4AS cells and confirmed that 
although 53BP1 is present at normal levels in these cells, it fails 
to localize to sites of DNA damage (Fig. 4, F and G). Impor-
tantly, RNF168 knockout cells ceased proliferating after centro-
some loss, demonstrating that localization of 53BP1 to sites of 
DNA damage is not required for it to function in the centrosome 
surveillance pathway (Fig. 4 H). These data suggest that 53BP1 
plays a DNA damage–independent role in signaling through the 
centrosome surveillance pathway.
Finally, we tested the ability of cells lacking p53, 53BP1, 
or USP28 to proliferate after doxorubicin-induced DNA dam-
age. As expected, treatment of Plk4AS cells with doxorubicin 
dramatically reduced the fraction of cells that entered into S 
phase, as well as clonogenic survival (Figs. 4 I and S3 C). Al-
though p53−/− cells progressed into S phase and formed colonies 
in the presence of doxorubicin, USP28−/− and 53BP1−/− cells 
did not. This demonstrates that the DNA damage response re-
mains partly intact in cells lacking USP28 and 53BP1. Collec-
tively, our evidence strongly indicates that DNA damage is not 
responsible for activating the centrosome surveillance pathway.
The cell cycle arrest induced by prolonged 
prometaphase requires the same 
signaling components as the centrosome 
surveillance pathway
To evaluate the effect of centrosome loss on mitotic duration, 
we grew p53−/−, 53BP1−/−, and USP28−/− Plk4AS cells in 3MB-
PP1 for 6 d and measured the length of mitosis in cells that lack 
centrosomes. Loss of centrosomes dramatically extended the 
duration of mitosis (mean of 153, 129, and 149 min in p53−/−, 
53BP1−/−, and USP28−/− cells, respectively; Fig.  5 A). Previ-
ous work has shown that prolonging prometaphase to >90 min 
leads to p53-dependent arrest in RPE1 cells (Uetake and Sluder, 
2010). This suggests that this mitotic timer may be dysfunc-
tional in p53−/−, 53BP1−/−, and USP28−/− cells. To investigate 
this possibility, we first set out to determine the window of 
tolerance for prometaphase duration in the Plk4AS RPE1 cells 
used in this study. Plk4AS cells were treated with nocodazole 
for 6 h, and after drug washout, the proliferative fate of daugh-
ter cells monitored by time-lapse microscopy. Although 13% 
of daughters whose mothers spent <120 min in prometaphase 
failed to proliferate, prolonging the duration of prometaphase 
to >120 min caused a cell cycle arrest in 88% of the resulting 
daughters (Fig.  5 A). Although this response is not as robust 
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as reported in unmodified hTERT-RPE1 cells, the mitotic 
timer is clearly functioning in Plk4AS cells (Uetake and Sluder, 
2010; Wong et al., 2015).
We next investigated whether the newly identified compo-
nents of the centrosome surveillance pathway are also required 
to arrest cells after an increased mitotic duration. Consistent 
with previous work, nearly all p53−/− daughter cells proliferated 
regardless of the prometaphase duration in the preceding divi-
sion (Fig. 5 B; Uetake and Sluder, 2010). Remarkably, knockout 
of USP28 and 53BP1 almost completely abolished the G1 arrest 
after a prolonged prometaphase. We conclude that the stresses 
generated by both centrosome loss and an extended prometa-
phase act through the same signaling components to stabilize 
p53 and cause a cell cycle arrest.
Because the centrosome surveillance pathway and the mi-
totic timer require the same components, we investigated whether 
activation of the mitotic timer could account for the cell cycle ar-
rest that occurs in Plk4AS cells after centrosome loss. To examine 
the effect of centrosome loss on cell division time, we monitored 
Plk4AS cells by time-lapse microscopy at 1, 2, and 3 d after Plk4 
inhibition. Untreated control cells progressed though mitosis with a 
mean time of 25 min (Fig. 5 C). Mitotic duration increased as cells 
progressed through successive divisions in the absence of Plk4 ac-
tivity (mean of 40 min at 1 d, 60 min at 2 d, and 65 min at 3 d after 
3MB-PP1 addition). Nevertheless, no mitosis exceeded a duration 
required to activate the mitotic timer (>120 min), suggesting that 
activation of the centrosome surveillance pathway cannot be sim-
ply explained by an increase in duration of a single division.
Distinct signal transduction cascades 
activate p53 in response to centrosome 
amplification or centrosome loss
We previously showed that Plk4 overexpression promotes cen-
trosome amplification and a p53-dependent cell cycle arrest in 
hTERT-RPE1 cells (Holland et al., 2012). We therefore tested 
whether the proteins required to block proliferation after centro-
some loss are also required to prevent cell growth in the pres-
ence of extra centrosomes. Although knockout of p53, and to a 
lesser extent p21, allowed for the growth of Plk4-overexpressing 
cells with supernumerary centrosomes, knockout of 53BP1 
and USP28 did not (Fig. S3 D). A recent study showed that 
extra centrosomes trigger activation of the Hippo pathway ki-
nase LATS2, which in turn stabilizes p53 (Ganem et al., 2014). 
However, knockout of LATS1 or LATS2 did not prevent growth 
arrest in cells after either centrosome loss or gain (Fig. S3, E 
and F). Collectively, these data suggest that distinct signaling 
pathways activate p53–p21 in response to centrosome loss or 
the presence of excess centrosomes (Fig. 5 D).
Our results reveal the existence of a USP28–53BP1–p53–
p21 signaling axis that arrests cell cycle progression after cen-
trosome loss. USP28 and p53 both bind to 53BP1 through the 
tandem C-terminal BRCT repeats (Joo et al., 2002; Knobel et al., 
2014). We therefore speculate that 53BP1 could recruit USP28 to 
deubiquitinate and stabilize p53 in response to centrosome loss 
(Fig. 5 D). Although DNA breaks trigger p53 activation, several 
lines of evidence strongly suggest that DNA damage is not re-
sponsible for activating the centrosome surveillance pathway. 
Figure 4. The DNA damage response and 
centrosome surveillance pathway are geneti-
cally separable. (A) Immunoblot showing the 
level of various proteins at 1, 2 or 3 d after 
addition of DMSO or 3MB-PP1. (B) Fraction of 
cells with more than five 53BP1 foci at times 
after addition of DMSO or 3MB-PP1. doxo, 
doxorubicin; untr, untreated. Data are means 
± SEM (n = 3, >50 cells per experiment). (C) 
Immunoblot showing protein levels in Plk4AS; 
Chk2−/− cells. (D) Representative images of 
crystal violet–stained colonies. (E) Relative clo-
nogenic survival of 3MB-PP1 or 10 ng/ml doxo-
rubicin–treated Plk4AS cells. Data are means ± 
SEM (n = 3). (F) Immunoblot showing protein 
levels in Plk4AS; RNF168−/− cells. (G) Images 
show the loss of 53BP1 foci formation in doxo-
rubicin-treated Plk4AS; RNF168−/− cells. Bar, 5 
µm. (H) Graph shows the relative clonogenic 
survival of Plk4AS and Plk4AS; RNF168−/− cells 
treated with 3MB-PP1. Data are means ± SEM 
(n = 3). (I) Graph showing the relative clono-
genic survival of 10 ng/ml doxorubicin-treated 
Plk4AS cells. Data are means ± SEM (n = 3). ns 
(nonsignificant), P > 0.05; *, P ≤ 0.05.
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First, there is no detectable DNA damage in cells that fail 
centrosome duplication. Second, knockout of bona fide DNA 
damage components, including ATM, Chk1, Chk2, RNF8, and 
RNF168 do not prevent cell cycle arrest after centrosome loss. 
Third, preventing 53BP1 localization to sites of DNA damage 
prevents DNA damage-dependent functions of 53BP1, but it 
does not prevent growth arrest after a failure of centrosome du-
plication. Finally, although loss of USP28 or 53BP1 prevents 
activation of p53 in response to centrosome loss, their loss does 
not prevent p53 stabilization and cell cycle arrest in cells treated 
with the DNA damaging agent doxorubicin.
At present, the mechanism by which cells “sense” cen-
trosome loss remains unclear. Although it is possible that the 
centrosome surveillance pathway directly monitors centro-
some number, we feel this is unlikely for two reasons. First, 
p53, 53BP1, and USP28 do not localize to the centrosome in 
RPE1 cells (Fig. S3 G). Second, our evidence suggests that 
there are distinct pathways that activate p53 in cells with either 
too few or too many centrosomes, arguing against a common 
mechanism for detecting the wrong number of centrosomes. 
Therefore, we favor the interpretation that p53 activation is 
indirectly triggered by a stress associated with cell cycle pro-
gression after centrosome loss.
We have shown that, as well as being required for the 
centrosome surveillance pathway, USP28, 53BP1, and p53 are 
also required to prevent the growth of cells that delay in mito-
sis. This raises the possibility that the centrosome surveillance 
pathway is activated by a prolonged mitosis. Nevertheless, 
cells that fail centriole duplication delay in mitosis but do not 
exceed a mitotic duration in a single division that is sufficient 
to activate the mitotic timer (Lambrus et al., 2015; Wong et 
al., 2015). Because cells that fail centrosome duplication typ-
ically undergo three or four cell divisions before they cease 
proliferating, it is possible that the cumulative stress from suc-
cessive delayed cell divisions eventually passes a threshold 
that triggers an arrest in cells failing centrosome duplication. 
Interestingly, 53BP1 localizes to unattached kinetochores in 
prometaphase, suggesting that it could play a signaling role 
during mitosis (Fig. S3 G; Jullien et al., 2002). Determining 
whether kinetochore localization of 53BP1 is required for the 
centrosome surveillance pathway and mitotic timer is an im-
portant area of future work.
Figure 5. Prolonged prometaphase and centrosome loss signal through the same components to arrest the cell cycle. (A) Mitotic duration in histone H2B-
EGFP–expressing p53−/−, 53BP1−/−, and USP28−/− Plk4AS cells, grown in either DMSO or 3MB-PP1 for 6 d. Data are means ± SEM (n = 2, >25 cells 
per experiment). (B) Schematic of the mitotic timer experiment. Graph shows the prometaphase duration and proliferative capacity of 3MB-PP1–treated 
Plk4AS cells. Each bar represents a daughter cell; its height represents the prometaphase duration of the mother cell, and its color represents the fate of the 
daughter. The dashed red line indicates the maximum time that mother cells spend in prometaphase before >85% of daughter cells undergo a cell cycle 
arrest. (C) Mitotic duration in histone H2B-EGFP–expressing Plk4AS cells. Measurements were taken over a 24-h period at indicated times after 3MB-PP1 
addition. Data are means ± SEM (n = 2, >25 cells per experiment). (D) A model for stress signaling inputs into the mitotic surveillance pathway. *, P ≤ 
0.05; **, P ≤ 0.01; ***, P ≤ 0.001.
 o
n
 Septem
ber 19, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published July 18, 2016
JCB • Volume 214 • NumBer 2 • 2016150
Materials and methods
Cell culture
hTERT-RPE-1 cells were grown in DMEM :F12 medium (Cellgro; 
Corning) containing 10% fetal bovine serum (Sigma-Aldrich), 0.348% 
sodium bicarbonate, 100 U/ml penicillin, 100 U/ml streptomycin, 
and 2 mM l-glutamine. 293FT cells were grown in DMEM medium 
(Cellgro; Corning) containing 10% fetal bovine serum (Sigma-
Aldrich), 100 U/ml penicillin, 100 U/ml streptomycin, and 2  mM 
l-glutamine. Cells were maintained at 37°C in a 5% CO2 atmosphere 
with 21% oxygen. 3MB-PP1 (EMD Millipore) was dissolved in 
DMSO and used at a final concentration of 10 µM. Centrinone (a gift 
from K.  Oegema, Ludwig Institute for Cancer Research, La Jolla, 
CA) was dissolved in DMSO and used at a final concentration of 125 
nM. Cycloheximide (Sigma-Aldrich) was dissolved in water and used 
at a final concentration of 50 µg/ml. KU-55933 (Tocris Bioscience) 
was dissolved in DMSO and used at a final concentration of 10 µM. 
Nutlin-3 (Cayman Chemical) was dissolved in DMSO and used at 
a final concentration of 10  µM. Doxorubicin (Sigma-Aldrich) was 
dissolved in DMSO and used at a final concentration of 200 ng/ml 
unless otherwise stated.
Creation of Plk4AS hTERT-RPE1 cells
To facilitate genome editing, we set out to knock out out the puro-
mycin acetyltransferase (PAC) expressed in hTERT-RPE-1 cells. An 
sgRNA targeting PAC (5′-TGT CGA GCC CGA CGC GCG TG-3′) was 
cloned into the px458 expression vector (48138; Addgene) that co-
expresses the sgRNA from a U6 promoter and SpCas9-2A-GFP from 
a cytomegalovirus (CMV) promoter. Cells were transfected with 
the px458 plasmid and GFP-positive single cells isolated by FACS. 
Clones were split into duplicate wells, and one well received 3 µg/ml 
puromycin. A clone that showed complete cell death after 3 d of 
puromycin treatment was selected and used in all experiments 
described in this paper.
Plk4 gene targeting was performed in hTERT-RPE-1 cells 
using CRI SPR/Cas9. In brief, a sgRNA targeting Plk4 (5′-AGA TAG 
CAA TTA TGT GTA TC-3′) was cloned into the px459 expression vec-
tor (48139; Addgene) that coexpresses the sgRNA from a U6 pro-
moter and SpCas9-2A-puromycin from a CMV promoter. Cells were 
cotransfected with a 1:20 molar ratio of the px459 plasmid and a 160-bp 
single-stranded oligonucleotide repair template. The repair template 
introduced the L89G mutation, a silent AflIII restriction site, and a mu-
tation in the SpCas9 protospacer-adjacent motif to prevent re-cutting 
after homology-directed repair. Transfected cells were selected for 3 d 
with 3 µg/ml puromycin, and single clones were isolated by limiting 
dilution. Genomic DNA was isolated from single clones and subjected 
to PCR using the following primers: forward, 5′-GCA GGA ATG GTA 
CAG AGA GTCC-3′; reverse, 5′-GCA AAA CTT TTA TCC ACC CAAA-
3′. PCR products were digested with AflIII for 2 h. Clones with di-
gested PCR products were sequenced to verify insertion of the L89G 
mutation. A single clone was identified that possessed the L89G mu-
tation in one allele and a frameshift single-base-pair insertion in the 
second allele that led to the creation of a premature stop codon at 
amino acid 94 (L89G donor oligonucleotide: 5′-CTG AAT TTT TGT 
ATA TTT TAA TTT ATT ATG CCC TTT CAC ATT TCA GCT TTA TAA CTA 
TTT TGA AGA TAG CAA TTA CGT GTA TCT AGT AGG AGA AAT GTG 
CCA TAA TGG AGA AAT GAA CAG GTA TCT AAA GAA TAG AGT GAA 
ACC CTT CTC AGA AAA TGA AG-3′).
Lentiviral production and transduction
The lentiCas9-Blasticidin (52962; Addgene), lentiGuide-Puromycin 
(52963; Addgene), or lentiGuide-Neomycin (this study) plasmid was 
cotransfected into 293FT cells with the lentiviral packaging plasmids 
psPAX2 and pMD2.G (12260 and 12259; Addgene). In brief, 8 × 106 
293FT cells were seeded into a poly-l-Lysine–coated 15-cm culture 
dish the day before transfection. For each 15-cm dish, the following 
DNA was diluted in 1.2 ml OptiMEM (Thermo Fisher Scientific): 9 µg 
lentiviral vector, 12 µg psPAX2, and 3 µg pMD2.G. Separately, 72 µl 
of 1 µg/µl 25-kD polyethylenimine (Sigma-Aldrich) was diluted into 
1.2 ml OptiMEM, briefly vortexed, and incubated at room temperature 
for 5 min. After incubation, the DNA and polyethylenimine mixtures 
were combined, briefly vortexed, and incubated at room temperature 
for 20 min. During this incubation, the culture media was replaced with 
17 ml prewarmed DMEM + 1% FBS. The transfection mixture was then 
added drop-wise to the 15-cm dish. Viral particles were harvested 48 h 
after the media change and filtered through a 0.45-µm PVDF syringe fil-
ter. The filtered supernatant was either concentrated in 100 kD Amicon 
Ultra Centrifugal Filter Units (EMD Millipore) or used directly to infect 
cells. Aliquots were snap-frozen and stored at −80°C. For transduction, 
lentiviral particles were diluted in complete growth media supplemented 
with 10 µg/ml polybrene (Sigma-Aldrich) and added to cells.
CRI SPR/Cas9 GeCKO screen
CRI SPR/Cas9 pooled, knockout screens were performed essentially 
as described previously (Shalem et al., 2014; Chen et al., 2015). In 
brief, PAC knockout hTERT-RPE1 or Plk4AS hTERT-RPE1 cells were 
transduced with the lentiCas9-blasticidin virus and single cells sorted 
into 96-well plates to isolate clonal cell lines. Multiple clones were 
screened by immunoblot for the FLAG epitope fused to the Cas9 pro-
tein. A SpCas9-hTERT-RPE1 and Plk4AS-SpCas9-hTERT-RPE1 cell 
line with a high level of SpCas9 expression was selected for further use.
The human GeCKO v2 plasmid library was purchased from Ad-
dgene (1000000049) and plasmid DNA amplified according to the man-
ufacturer’s instructions. To produce virus, the GeCKO pooled plasmid 
library and the lentiviral packaging plasmids psPAX2 and pMD2.G were 
cotransfected into 40× 15-cm culture dishes of 293FT cells. Transfections 
were performed as described in the section above and viral particles were 
harvested, filtered, and concentrated. Aliquots were stored at −80°C.
Cells were transduced with the GeCKO library via spinfection. 
To find the optimal virus volumes for achieving an MOI ∼0.1, each 
new batch of virus was titered by spinfecting 3 × 106 cells with several 
different volumes of virus. In brief, 3 × 106 cells per well were seeded 
into a 12 well plate in growth media supplemented with 10 µg/ml 
polybrene. Each well received a different titrated virus amount (be-
tween 5 and 50 µl) along with a no-transduction control. The plate was 
centrifuged at 2,000 rpm for 2 h at room temperature. After the spin, 
media was aspirated and fresh growth media was added. The next day, 
cells were counted and each well was split into duplicate wells. One 
well received 3 µg/ml puromycin (Sigma-Aldrich) for 3 d. Cells were 
counted and the percent transduction calculated as the cell count from 
the replicate with puromycin divided by the cell count from the repli-
cate without puromycin multiplied by 100. The virus volume yielding a 
MOI closest to 0.1 was chosen for large-scale transductions. A MOI of 
0.1–0.2 corresponds to a single transduction percentage of 95% at 10% 
survival and 90% at 20% survival, respectively.
For the pooled screen a total of 12 × 107 SpCas9-hTERT-RPE1 
or Plk4AS-SpCas9-hTERT-RPE1 cells were infected at MOI ∼0.1 and 
selected with puromycin at 3 µg/ml for 3 d. MOI was calculated using a 
control well infected in parallel following the same procedure outlined 
in the paragraph above. Infected cells were expanded under puromycin 
selection for 7 d to allow editing to proceed to completion. After 7 d, 2 × 
107 cells were spun down and frozen for genomic DNA extraction. In ad-
dition, 12 × 106 cells were seeded into each of two 15-cm culture dishes. 
One dish was treated with DMSO and the other with either centrinone 
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(SpCas9-hTERT-RPE1 cells) or 3MB-PP1 (Plk4AS-SpCas9-hTERT-
RPE1 cells). Cells were either passaged or fresh media was added every 
3–4 d. Cell pellets with a minimum of 2 × 107 cells were taken at 42 d 
after drug addition at which point the screen was terminated.
Frozen cell pellets were thawed and genomic DNA was extracted 
with a GenElute Mammalian Genomic DNA extraction kit (Sigma- 
Aldrich). The sgRNA library for each sample was amplified and pre-
pared for Illumina sequencing using a two-step PCR procedure, where 
the first PCR includes enough genomic DNA to preserve full library 
complexity and the second PCR adds appropriate sequencing adapters 
to the products from the first PCR. For the first PCR, a region containing 
the sgRNA cassette was amplified using primers specific to the sgRNA- 
expression vector (lentiGuide-PCR-F: 5′-AAT GGA CTA TCA TAT GCT 
TAC CGT AAC TTG AAA GTA TTT CG-3′; lentiGuide-PCR1-R: 5′-CTT 
TAG TTT GTA TGT CTG TTG CTA TTA TGT CTA CTA TTC TTT CC-3′).  
The thermocycling parameters for the first PCR were 98°C for 30 s; 
18–24 cycles of 98°C for 1  s, 62°C for 5  s, and 72°C for 35  s; and 
72°C for 1 min. 1.5 µg DNA was used in each PCR reaction. Assum-
ing 6.6 pg DNA per cell, ∼100× representation of the GeCKO library 
required ∼80 µg DNA per sample (54 PCR reactions). The resulting 
amplicons for each sample were pooled, gel purified, and used for am-
plification with barcoded second PCR primers. For each sample, we 
performed 14 reactions.
Primers for the second PCR include both a variable length se-
quence to increase library complexity and an 8-bp barcode for mul-
tiplexing of different biological samples (F2: 5′-AAT GAT ACG GCG 
 ACC ACC GAG ATC TAC ACT CTT TCC CTA CAC GAC GCT CTT CCG 
ATCT-3′ [4–7-bp random nucleotides; 8-bp barcode], 5′-TCT TGT 
GGA AAG GAC GAA ACA CCG-3′; R2: 5′-CAA GCA GAA GAC GGC 
 ATA CGA GAT GTG ACT GGA GTT CAG ACG TGT GCT CTT CCG ATC 
TTC TAC TAT TCT TTC CCC TGC ACT GT-3′). 
5 µl of the product from the first PCR reaction was used, and the 
thermocycling parameters for the second PCR were 98°C for 30 s and 
18–24 cycles of 98°C for 1 s, 70°C for 5 s, 72°C for 35 s. Second PCR 
products were pooled, gel purified, and quantified using the Next Li-
brary Quantification kit (New England Biolabs, Inc.). Diluted libraries 
with 5% PhiX were sequenced with MiSeq (Illumina).
Sequencing data were processed for sgRNA representation using 
custom scripts. In brief, sequencing reads were first demultiplexed 
using the barcodes in the forward primer and then trimmed to leave 
only the 20 bp sgRNA sequences. The spacer sequences were then 
mapped to the spacers of the designed sgRNA library using Bowtie 
(Langmead et al., 2009). For mapping, a maximum of one mismatch 
was allowed in the 20-bp sgRNA sequence. Mapped sgRNA sequences 
were then quantified by counting the total number of reads. The total 
numbers of reads for all sgRNAs in each sample were normalized. 
Genes were ranked using the MaGeCK algorithm, which takes into ac-
count sgRNA enrichment as well as the number of sgRNAs targeting a 
particular gene (Li et al., 2014).
Antibody techniques
For immunoblot analyses, protein samples were separated by SDS-
PAGE, transferred onto nitrocellulose membranes with a Trans-Blot 
Turbo Transfer System (Bio-Rad Laboratories) and then probed with 
the following antibodies: YL1/2 (rat anti–α-tubulin, 1:3,000; Pierce 
Antibodies), p53 (mouse, 1:1,000; EMD Millipore), 53BP1 (rabbit, 
1:2,000; Novus Biologicals), MDM2 (mouse, 1:1,000; Thermo Fisher 
Scientific), Chk2 (mouse, 1:500; EMD Millipore), phospho-KAP1 
(Ser824, rabbit, 1:1,000; Bethyl Laboratories, Inc.), p-histone H2A.X 
(Ser139; rabbit, 1:1,000; Cell Signaling Technology), phospho-p53 
(Ser15, rabbit 1:1,000; Cell Signaling Technology), CDKN1A (rab-
bit, 1:1,000; NeoBioLab), RNF168 (rabbit, 1:1,000; EMD Millipore), 
LATS1 (rabbit, 1:1,000; Cell Signaling Technology), LATS2 (rab-
bit, 1:1,000; Cell Signaling Technology), and FLAG M2 (mouse, 
1:1,000; Sigma-Aldrich).
For immunofluorescence, cells were grown on 18-mm glass cov-
erslips and fixed for 10 min in either 4% formaldehyde at room tem-
perature, or 100% ice cold methanol at −20°C for 10 min. Cells were 
blocked in 2.5% FBS, 200 mM glycine, and 0.1% Triton X-100 in PBS 
for 1  h.  Antibody incubations were conducted in the blocking solu-
tion for 1 h. DNA was stained with DAPI and cells were mounted in 
ProLong Gold Antifade (Invitrogen). Staining was performed with the 
following primary antibodies: p53 (mouse, 1:1,000; EMD Millipore), 
53BP1 (rabbit, 1:2,000; Novus Biologicals), 53BP1 (mouse, 1:1,000; 
EMD Millipore), USP28 (rabbit, 1:1,000; Proteintech), FLAG M2 
(mouse, 1:1,000; Sigma-Aldrich), p-histone H2A.X (Ser139, rabbit, 
1:1,000; Cell Signaling Technology), centrin (mouse, 1:1,000; EMD 
Millipore), CEP192-Cy5 (directly labeled goat, raised against CEP192 
aa 1–211, 1:1,000; this study), and BUB1 (sheep, raised against BUB1 
aa 336–489, 1:1,000; a gift from S. Taylor, the University of Manches-
ter, Manchester, England, UK). Secondary donkey antibodies were 
conjugated to Alexa Fluor 488, 555, or 650 (Thermo Fisher Scientific).
For analysis of EdU incorporation, cells were pulsed with EdU 
for 12 h before fixation in 100% ice-cold methanol at −20°C for 10 
min. Cells were washed three times with PBST and stained using a 
Click-It EdU Alexa Fluor 555 imaging kit (Thermo Fisher Scientific).
Immunofluorescence images were collected using a Deltavision 
Elite system (GE Healthcare) controlling a Scientific CMOS camera 
(pco.edge 5.5). Acquisition parameters were controlled by SoftWoRx 
suite (GE Healthcare). Images were collected at room temperature 
(25°C) using an Olympus 40× 1.35 NA, 60× 1.42 NA or Olympus, or 
100× 1.4 NA oil objective at 0.2-µm z-sections. Images were acquired 
using Applied Precision immersion oil (n = 1.516). For quantitation of 
nuclear p53 signal intensity, 2D maximum intensity projections were 
saved as 16-bit TIFF images, and DAPI signal was used to threshold 
nuclei as regions of interest. For each nucleus, the integrated den-
sity of p53 signal was divided by nuclear area to give a signal/area 
value. Data were averaged over all cells in the panel and normalized 
to untreated population.
Live-cell microscopy
EGFP-tagged histone H2B was cloned into the FUGW backbone under 
the control of the CMV promoter and introduced into Plk4AS cells 
using lentiviral delivery.
Histone H2B-EGFP–expressing Plk4AS cells were seeded into 
four-chamber, 35-mm glass-bottom culture dishes (Greiner) and main-
tained at 37°C in an environmental control station. Images were col-
lected using a Deltavision Elite system (GE Healthcare) controlling 
a Scientific CMOS camera (pco.edge 5.5.). Images were acquired 
with an Olympus 20× 0.75 NA air objective. Every 5 min, 7 × 3-µm 
z-sections were acquired in the FITC channel and by differential in-
terference contrast. Movies were assembled and analyzed in FIJI. Mi-
totic duration was calculated as the time taken from nuclear envelope 
breakdown to mitotic exit.
Mitotic timer experiments tracing
For nocodazole treatment, coverslips were assembled into observation 
chambers with medium containing 0.08  µM nocodazole, and fields 
of cells were continuously followed by video time-lapse microscopy 
at 37°C for 6 h. After 6 h, the field of view was marked with a dia-
mond scribe; the bottom of the observation chamber was removed and 
washed out with fresh medium several times before being reassembled 
with fresh medium as previously described (Uetake and Sluder, 2012). 
The previously marked fields were continuously followed for at least 
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96 h. Images were collected using a DMR XE microscope (Leica Biosys-
tems) equipped with phase-contrast optics and a 10× 0.3 NA objective 
(Leica Biosystems). Images were captured with an Orca ER (Hama-
matsu Photonics) camera using HCT software (Hamamatsu Photonics) 
and exported as AVI movies to be viewed with QuickTime (Apple).
Cell biology
To prepare cells for flow cytometry, cell pellets were fixed in cold 70% 
EtOH for 24  h, washed once in PBS, and resuspended in PBS sup-
plemented with 10 µg/ml RNase A and 50 µg/ml propidium iodide. 
Samples were incubated at room temperature for 30 min and analyzed 
on a flow cytometer (FAC SCalibur; BD). For clonogenic assays, 500 
cells were seeded in a 10-cm2 culture dish and left to grow for ∼10 d 
until colonies were visible by eye. Cells were fixed in methanol for 30 min 
at room temperature and colonies were stained with crystal violet 
(Sigma-Aldrich). Plates were imaged on a G:BOX Chemi XX6 (Syngene) 
and the fraction of the dish upon which growth occurred was determined 
using GeneSys software (Syngene). The percentage of clonogenic survival 
was calculated by dividing the area of growth in the presence of 3MB-PP1 
by the area of growth of control DMSO-treated cells multiplied by 100.
Statistics
Differences were determined by one-tailed t test and are anno-
tated as nonsignificant (ns; P > 0.05); *, P ≤ 0.05; **, P ≤ 0.01; 
and ***, P ≤ 0.001.
Online supplemental material
Fig. S1 shows inhibition of Plk4 kinase activity activates the 
centrosome surveillance pathway and prevents cell growth. Fig. S2 
shows USP28−/− and 53BP1−/− cells activate p53 in response to DNA 
damage, but not after centrosome loss. Fig. S3 shows knockout of 
53BP1 or USP28 does not allow growth in cells overexpressing Plk4. 
Online supplemental material is available at http ://www .jcb .org /cgi /
content /full /jcb .201604054 /DC1.
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